These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein. Saville B; Poukka H; Wormke M; Janne OA; Palvimo JJ; Stoner M; Samudio I; Safe S J Biol Chem; 2002 Jan; 277(4):2485-97. PubMed ID: 11696545 [TBL] [Abstract][Full Text] [Related]
64. Transactivation and Coactivator Recruitment Assays for Measuring Farnesoid X Receptor Activity. Hsu CW; Zhao J; Xia M Methods Mol Biol; 2016; 1473():43-53. PubMed ID: 27518622 [TBL] [Abstract][Full Text] [Related]
65. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells. Bai Y; Giguére V Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772 [TBL] [Abstract][Full Text] [Related]
66. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II). Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223 [TBL] [Abstract][Full Text] [Related]
67. Estrogen response element and the promoter context of the human and mouse lactoferrin genes influence estrogen receptor alpha-mediated transactivation activity in mammary gland cells. Stokes K; Alston-Mills B; Teng C J Mol Endocrinol; 2004 Oct; 33(2):315-34. PubMed ID: 15525592 [TBL] [Abstract][Full Text] [Related]
68. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor. Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532 [TBL] [Abstract][Full Text] [Related]
69. A Time-Resolved FRET Cell-Based Binding Assay for the Apelin Receptor. Valencia C; Dujet C; Margathe JF; Iturrioz X; Roux T; Trinquet E; Villa P; Hibert M; Dupuis E; Llorens-Cortes C; Bonnet D ChemMedChem; 2017 Jun; 12(12):925-931. PubMed ID: 28374567 [TBL] [Abstract][Full Text] [Related]
70. A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation. Marine S; Zamiara E; Smith ST; Stec EM; McGarvey J; Kornienko O; Jiang G; Wong KK; Stack JH; Zhang BB; Ferrer M; Strulovici B Anal Biochem; 2006 Aug; 355(2):267-77. PubMed ID: 16797469 [TBL] [Abstract][Full Text] [Related]
71. The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain. Tian H; Mahajan MA; Wong CT; Habeos I; Samuels HH Mol Endocrinol; 2006 Sep; 20(9):2036-51. PubMed ID: 16645037 [TBL] [Abstract][Full Text] [Related]
72. POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening. Lanne A; Bardelle C; Davies G; Turberville A; Semple H; Moore R; Holdgate GA SLAS Discov; 2024 Jun; 29(4):100156. PubMed ID: 38642710 [TBL] [Abstract][Full Text] [Related]
73. Tetrabromobisphenol-A disrupts thyroid hormone receptor alpha function in vitro: use of fluorescence polarization to assay corepressor and coactivator peptide binding. Lévy-Bimbot M; Major G; Courilleau D; Blondeau JP; Lévi Y Chemosphere; 2012 May; 87(7):782-8. PubMed ID: 22277881 [TBL] [Abstract][Full Text] [Related]
75. Genetically Encoded FRET-Sensor Based on Terbium Chelate and Red Fluorescent Protein for Detection of Caspase-3 Activity. Goryashchenko AS; Khrenova MG; Bochkova AA; Ivashina TV; Vinokurov LM; Savitsky AP Int J Mol Sci; 2015 Jul; 16(7):16642-54. PubMed ID: 26204836 [TBL] [Abstract][Full Text] [Related]
76. The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain. Folkertsma S; van Noort PI; de Heer A; Carati P; Brandt R; Visser A; Vriend G; de Vlieg J Mol Endocrinol; 2007 Jan; 21(1):30-48. PubMed ID: 17038419 [TBL] [Abstract][Full Text] [Related]
77. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators. Jaber BM; Gao T; Huang L; Karmakar S; Smith CL Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538 [TBL] [Abstract][Full Text] [Related]
78. QTR-FRET: Efficient background reduction technology in time-resolved förster resonance energy transfer assays. Syrjänpää M; Vuorinen E; Kulmala S; Wang Q; Härmä H; Kopra K Anal Chim Acta; 2019 Dec; 1092():93-101. PubMed ID: 31708038 [TBL] [Abstract][Full Text] [Related]
79. Tryptophan and tyrosine to terbium fluorescence resonance energy transfer as a method to "map" aromatic residues and monitor docking. Allen JE; McLendon GL Biochem Biophys Res Commun; 2006 Nov; 349(4):1264-8. PubMed ID: 16979582 [TBL] [Abstract][Full Text] [Related]
80. Gold Nanoparticle-Based Förster Resonance Energy Transfer (FRET) Analysis of Estrogen Receptor: DNA Interaction. Su X; Aung KMM; Lukman S; Liu B Methods Mol Biol; 2016; 1366():219-232. PubMed ID: 26585138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]